About Index Trending news
Lists
Pricing
Rigontec GmbH

Rigontec GmbH

Elsewhere

Alexa global traffic share

Latest funding
Employees

Unknown size

Locations
HQ
Headquarters
PE Hub

Merck to buy VC-backed Rigontec

Health Funding
rigontec

Rigontec GmbH – A Dual Approach To Treat Cancer is a privately held biopharmaceutical company that develops RNA-based immunotherapeutics for the treatment of cancer and viral diseases.

Health Science Funding
€15,000,000 Venture capital (Series A)
FinSMEs

Rigontec Raises €15M in Third Closing of Series A Funding

Funding Health